Michael Guastella By Natalie Morrison 11-Oct-2011 - Last updated on 12-Oct-2011 at 09:42 GMT Facebook Twitter Linkedin Email to a friend He replaces founding executive director Henry Kramer, who will retire later this year.Guastella was most recently theVP of marketing and product development for the Nuclear Pharmacy Business of Cardinal Health – a position he held for seven years. Bryce Carmine, retiring as leader of Eli Lilly Bio-Medicines Frank Deane, retiring as Eli Lilly's head of global manufacturing operations Dave Ricks, new senior VP and president of Lilly Bio-Medicines Alex Azar, Eli Lilly USA president Maria Crowe, new head of global manufacturing operations at Eli Lilly Harsukh Parmar Roche's head of translational and experimental medicine (TM) for the inflammation discovery and translational area Kenneth Frazier (left), new Merck chairman following the retirement of Richard Clark Michael Guastella, executive director for the Council of Radionuclides and Radiopharmaceuticals (CORAR) John Butler, CEO at Inspiration Biopharmaceuticals Prev 1 … 5 6 7 8 9 Next